Stay updated on Pembrolizumab and TKI in CML MRD Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and TKI in CML MRD Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and TKI in CML MRD Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page shows a new Revision: v3.3.2 added and a Revision: v3.3.1 removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T16:42:39.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision updated from v3.2.0 to v3.3.1.
    Difference
    0.0%
    Check dated 2025-11-24T11:09:51.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    Recent update dates (2025-11-11 and 2025-11-13) appear on the study page, and an older funding notice was removed. These are maintenance updates that do not alter study content or results; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-16T05:59:48.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Updates to the study record history show new Last Update posts dated 2025-10-29 and 2025-10-28, with removals of September entries. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-02T00:17:43.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a new government-operating status notice and funding caveat; removes v3.1.0. This introduces current-operational caveats and directs users to status pages.
    Difference
    1%
    Check dated 2025-10-04T04:26:18.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Update: refresh of metadata with newer dates and a new revision (v3.1.0) replacing older metadata (v3.0.2); overall, the changes are primarily about versioning and update timestamps rather than core content.
    Difference
    0.3%
    Check dated 2025-09-27T02:23:57.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and TKI in CML MRD Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and TKI in CML MRD Clinical Trial page.